Wall Street turned bullish on several names on Wednesday. Healthcare and materials stocks led the upgrades.
Johnson & Johnson got the most notable call of the day. Leerink Partners upgraded the stock from Hold to Buy. Analyst David Risinger set a price target of $265. The pharma giant carries a $540 billion market cap. Short interest sits at just under 1% of free float — bears are not in this trade.
The Mosaic Company also received an upgrade. The fertilizer producer moved to a more bullish consensus. Analysts lifted their average target to $27.56. Mosaic has a $7.1 billion market cap. Short interest is 5.5% of free float — modest but worth watching if the upgrade cycle builds.
AbbVie saw its average analyst target nudge higher to $252.93. The consensus remains firmly in hold-to-buy territory. AbbVie holds a $367 billion market cap.
Digital Realty Trust also got a target price boost today. Analysts raised their average to $217.90 on the data-centre REIT.
On the downside, PepsiCo saw its target trimmed. The average slipped to $171.29 from $172.10. drew multiple changes from analysts, with its buy consensus count shifting slightly negative.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
